These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 17308261)
21. Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA). Ribrag V; Gisselbrecht C; Haioun C; Salles G; Golfier JB; Ertault M; Ferme C; Briere J; Brice P; Mounier N Cancer; 2009 Oct; 115(19):4540-6. PubMed ID: 19593797 [TBL] [Abstract][Full Text] [Related]
22. Use of rituximab in combination with conventional chemotherapy for the treatment of non-Hodgkin's lymphoma of the head and neck. Manolopoulos L; Gomatos IP; Leandros E; Alevizos L; Georgiou N; Giotakis J; Ferekidis E In Vivo; 2009; 23(3):475-8. PubMed ID: 19454517 [TBL] [Abstract][Full Text] [Related]
23. Current status of the treatment of HIV-associated lymphoma. Kaplan LD Clin Adv Hematol Oncol; 2004 Jan; 2(1):28-9. PubMed ID: 16163156 [No Abstract] [Full Text] [Related]
25. Rituximab: new indication. In aggressive non Hodgkin lymphoma: benefits must be confirmed. Prescrire Int; 2003 Aug; 12(66):125-6. PubMed ID: 12906019 [TBL] [Abstract][Full Text] [Related]
26. Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494). Sparano JA; Lee S; Chen MG; Nazeer T; Einzig A; Ambinder RF; Henry DH; Manalo J; Li T; Von Roenn JH J Clin Oncol; 2004 Apr; 22(8):1491-500. PubMed ID: 15084622 [TBL] [Abstract][Full Text] [Related]
27. Initial chemotherapy with an age-adjusted CHOP-schedule in non-Hodgkin lymphomas with unfavorable prognosis. A study of the I.G.C.I. Heinz R; Pawlicki M; Losonczy H; Varbiro M; Benedek S; Konopka L; Krc I; Brugiatelli M Haematologica; 1986; 71(6):473-9. PubMed ID: 3104156 [No Abstract] [Full Text] [Related]
28. Impact of concomitant antiblastic chemotherapy and highly active antiretroviral therapy on human immunodeficiency virus (HIV) viremia and genotyping in HIV-infected patients with non-Hodgkin lymphoma. Simonelli C; Zanussi S; Cinelli R; Dal Maso L; Di Gennaro G; D'Andrea M; Nasti G; Spina M; Vaccher E; De Paoli P; Tirelli U Clin Infect Dis; 2003 Sep; 37(6):820-7. PubMed ID: 12955644 [TBL] [Abstract][Full Text] [Related]
29. [Evaluation of the response of advanced diffuse large cell lymphomas (LSG classification) to weekly CHOP therapy]. Shimizu K; Hara K; Kunii A Rinsho Ketsueki; 1989 Mar; 30(3):309-15. PubMed ID: 2769954 [TBL] [Abstract][Full Text] [Related]
30. Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Barta SK; Xue X; Wang D; Tamari R; Lee JY; Mounier N; Kaplan LD; Ribera JM; Spina M; Tirelli U; Weiss R; Galicier L; Boue F; Wilson WH; Wyen C; Oriol A; Navarro JT; Dunleavy K; Little RF; Ratner L; Garcia O; Morgades M; Remick SC; Noy A; Sparano JA Blood; 2013 Nov; 122(19):3251-62. PubMed ID: 24014242 [TBL] [Abstract][Full Text] [Related]
31. Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma. Barta SK; Lee JY; Kaplan LD; Noy A; Sparano JA Cancer; 2012 Aug; 118(16):3977-83. PubMed ID: 22180164 [TBL] [Abstract][Full Text] [Related]
32. Serbian lymphoma study group (SLG): the prognosis of AIDS-related non-Hodgkin's lymphoma. Djunic I; Jevtovic DL; Ranin J; Salemovic D; Tomin D; Mihaljevic B Biomed Pharmacother; 2008 Jan; 62(1):12-5. PubMed ID: 17629445 [TBL] [Abstract][Full Text] [Related]
33. Human immunodeficiency virus-associated diffuse non-Hodgkin's lymphoma in Venezuelan patients: treatment with full-dose cyclophosphamide-doxorubicin-vincristine-prednisone without routine use of granulocyte-colony stimulating factor. Hernàndez DE; Hernàndez AE Eur J Cancer Care (Engl); 2006 Dec; 15(5):493-6. PubMed ID: 17177909 [TBL] [Abstract][Full Text] [Related]
34. Primary anorectal lymphoma presenting as a perianal abscess in an HIV-positive male. Bhama JK; Azad NS; Fisher WE Eur J Surg Oncol; 2002 Mar; 28(2):195-7. PubMed ID: 11884058 [No Abstract] [Full Text] [Related]
36. Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin's lymphoma. Pedersen LM; Klausen TW; Davidsen UH; Johnsen HE Ann Hematol; 2005 Aug; 84(8):510-6. PubMed ID: 15834569 [TBL] [Abstract][Full Text] [Related]
37. [Prognostic factors of invasive non-Hodgkin's lymphoma]. Yu H; Hong XN; Li J; Peng LP; Ye L Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):461-3. PubMed ID: 17974284 [TBL] [Abstract][Full Text] [Related]
39. [Clinical outcomes of different regimens for non-Hodgkin's lymphoma with bone marrow involvement: analysis of 148 cases]. Li QC; Yuan XL; Wang YF; Zou DH; Zhao YZ; Qiu LG Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):254-7. PubMed ID: 18361837 [TBL] [Abstract][Full Text] [Related]
40. An unusual cause of pleural effusion. Youngster I; Vaisben E; Cohen H; Nassar F Age Ageing; 2006 Jan; 35(1):94-6. PubMed ID: 16364944 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]